HSE have published their latest bulletins:
Biocides
-
Upcoming GB active substance renewal submission deadlines
Apply for active substance renewal by the deadlines to keep products on the GB market
Under the GB BPR, active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR:
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10 (deadline: 28 December 2023)
- 2-bromo-ethanoic acid (Bromoacetic acid) (CAS 79-08-3 EC 201-175-8) in product type 4
(deadline: 28 December 2023)
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 6
(deadline: 28 December 2023)
- 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether (Etofenprox) (CAS 80844-07-1 EC 407-980-2) in product type 18 (deadline: 28 December 2023)
- Benzoic acid (CAS 65-85-0 EC 200-618-2) in product types 3 and 4 (deadline: 28 December 2023)
- Copper sulphate pentahydrate (CAS 7758-99-8 EC 231-847-6) in product type 2 (deadline: 28 December 2023)
- Nonanoic acid (Pelargonic acid) (CAS 112-05-0 EC 203-931-2) in product type 2 (deadline: 29 March 2024)
- (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin) (CAS 210880-92-5 EC 433-460-1) in product type 18 (deadline: 29 March 2025)
- 2-methyl-2H-isothiazol-3-one (MIT) (CAS 2682-20-4 EC 220-239-6) in product type 13
(deadline: 29 March 2025)
- Glutaral (Glutaraldehyde) (CAS 111-30-8 EC 203-856-5) in product types 2, 3, 4, 6, 11 and 12
(deadline: 29 March 2025)
- N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product types 7 and 9 (deadline: 29 March 2025)
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were.
If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know.
If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products of the relevant product types in GB.
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10 (deadline: 28 December 2023)
-
Upcoming EU active substance renewal submission deadlines
Apply for active substance renewal by the deadlines to keep products on the NI market
Under the EU BPR, active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date.
The 550-day deadlines are coming up for the following active substance/product type combinations under EU BPR. This affects NI:
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10 (deadline: 28 December 2023)
- 2-bromo-ethanoic acid (Bromoacetic acid) (CAS 79-08-3 EC 201-175-8) in product type 4
(deadline: 28 December 2023)
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 6
(deadline: 28 December 2023)
- 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether (Etofenprox) (CAS 80844-07-1 EC 407-980-2) in product type 18 (deadline: 28 December 2023)
- Benzoic acid (CAS 65-85-0 EC 200-618-2) in product types 3 and 4 (deadline: 28 December 2023)
- Copper sulphate pentahydrate (CAS 7758-99-8 EC 231-847-6) in product type 2 (deadline: 28 December 2023)
- Nonanoic acid (Pelargonic acid) (CAS 112-05-0 EC 203-931-2) in product type 2 (deadline: 29 March 2024)
- (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin) (CAS 210880-92-5 EC 433-460-1) in product type 18 (deadline: 29 March 2025)
- 2-methyl-2H-isothiazol-3-one (MIT) (CAS 2682-20-4 EC 220-239-6) in product type 13
(deadline: 29 March 2025)
- Glutaral (Glutaraldehyde) (CAS 111-30-8 EC 203-856-5) in product types 2, 3, 4, 6, 11 and 12
(deadline: 29 March 2025)
- N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product types 7 and 9 (deadline: 29 March 2025)
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the EU Article 95 List to see who the original supporters were.
If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under EU BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products of the relevant product types in Northern Ireland.
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10 (deadline: 28 December 2023)
-
Upcoming GB active substance open invitation deadline
Submit a notification by the deadline to keep active substances in the GB Review Programme
HSE has published an open invitation (.pdf) to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for the following active substance/product type combination. Anyone wishing to support the active substance/product type combination listed below in GB will need to submit a notification to HSE by the following deadline:
- Peanut butter (CAS n/a EC n/a) in product type 19 (deadline: 14 March 2024)
If a notification to take over the role of participant is not received, this active substance/product type combination will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market. HSE will provide separate updates on these where relevant. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us.
- Peanut butter (CAS n/a EC n/a) in product type 19 (deadline: 14 March 2024)
CLP:
-
ECHA public consultation: call for comments (Deadline: 1 December 2023)
The Great Britain Mandatory Classification and Labelling (GB MCL) process includes the consideration of information gathered from public consultations, conducted by HSE or international bodies such as the European Chemicals Agency (ECHA). ECHA has announced public a consultation on the following proposal for harmonised classification and labelling (CLH):
- acetophenone (EC 202-708-7; CAS: 98-86-2). Chemical registered under REACH. Health hazard classes open for commenting.
View the consultation on the ECHA website.
UK-based businesses with an interest in the proposal are strongly encouraged to share any relevant information.
Scientific and technical information should be submitted directly to ECHA using their commenting webform by 1 December 2023. Comments will be published on ECHA’s website.
If your business is affected by the GB CLP Regulation, please also consider if you are likely to be affected by the classification and labelling proposal and let us know at an early stage if you anticipate any significant impacts or benefits. Information on wider policy and impact considerations can be submitted to HSE at GBCLP.GBMCL@hse.gov.uk.
Under the GB CLP Regulation, HSE will consider all published opinions of the Committee of Risk Assessment of ECHA (RAC) before publishing its own Agency Technical Reports and Agency Opinions, so any information you provide will be important in any final GB MCL decision. More information on the new GB MCL system is available on the HSE website.
